To address the signs of aging caused by sun exposure and chronological aging on your face
Reagent enzyme-linked immunosorbent assay (ELISA) kits for tumor necrosis factor-alpha (TNF-
drug standards
BPC-157/TB-500 Blend (e.g., 5 mg BPC-157 + 5 mg TB-500 per vial) BPC-157 5mgTB-500 5mg Combo Chemical Components: BPC-157: Body Protection Compound-157 (pentadecapeptide) TB-500: Thymosin Beta-4 fragment (synthetic peptide fragment) Molecular Formula: BPC-157: CHNO TB-500 (fragment): CHNOS Molecular Weight: BPC-157: ~1,419.5 g/mol TB-500 (fragment): ~4,963 g/mol CAS Numbers: BPC-157: 137525-51-0 TB-500: 77591-33-4 Classification: Synthetic research peptide blend (dual-component) Purity: 99 % (HPLC-verified research grade) Appearance: White to off-white lyophilized (freeze-dried) powder Intended Use: For laboratory research only not approved for human or veterinary use
The few available human studies are small, unblinded, and often conducted by clinics with a stake in the outcome
These therapies aim to enhance WL and improve metabolic outcomes by engaging multiple hormonal pathways, with preclinical and early-phase clinical trials supporting their potential as next-generation obesity treatments [16,17,18,19,20,21,22,23]